US Stock MarketDetailed Quotes

CARA Cara Therapeutics

Watchlist
  • 0.295
  • +0.006+2.08%
Trading Oct 31 10:39 ET
16.18MMarket Cap-144P/E (TTM)

Cara Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
Total revenue
-85.71%991K
-65.37%2.14M
-49.92%20.97M
-7.88%3M
-55.00%4.87M
-69.86%6.93M
28.71%6.17M
81.81%41.87M
297.20%3.26M
-46.66%10.81M
Operating revenue
--0
-75.47%1.51M
-51.59%20.27M
-29.32%2.31M
-55.00%4.87M
-69.86%6.93M
28.71%6.17M
81.81%41.87M
297.20%3.26M
-46.66%10.81M
Cost of revenue
0
-76.06%620K
-15.03%6.17M
-71.46%608K
-49.00%1.56M
1.42M
24.46%2.59M
7.27M
2.13M
3.06M
Gross profit
-82.03%991K
-57.62%1.52M
-57.24%14.79M
111.85%2.4M
-57.36%3.31M
-76.02%5.52M
31.97%3.58M
50.26%34.6M
37.76%1.13M
-61.73%7.76M
Operating expense
-58.48%15.72M
-7.83%28.78M
11.59%136.29M
7.91%35M
1.91%32.21M
37.78%37.86M
1.98%31.23M
8.94%122.14M
-5.55%32.44M
47.71%31.6M
Selling and administrative expenses
-15.24%6.37M
-1.11%6.79M
-8.23%27.65M
2.39%6.55M
-2.27%6.72M
-0.32%7.51M
-26.33%6.86M
2.88%30.13M
-44.29%6.4M
17.59%6.88M
-General and administrative expense
-15.24%6.37M
-1.11%6.79M
-8.23%27.65M
2.39%6.55M
-2.27%6.72M
-0.32%7.51M
-26.33%6.86M
2.88%30.13M
-44.29%6.4M
17.59%6.88M
Research and development costs
-69.29%9.31M
-9.74%21.96M
18.10%108.51M
9.25%28.42M
3.08%25.45M
52.27%30.31M
14.39%24.33M
11.10%91.88M
13.92%26.01M
59.15%24.69M
Depreciation amortization depletion
25.81%39K
3.45%30K
1.56%130K
21.88%39K
-3.13%31K
-3.13%31K
-9.38%29K
2.40%128K
0.00%32K
3.23%32K
-Depreciation and amortization
25.81%39K
3.45%30K
1.56%130K
21.88%39K
-3.13%31K
-3.13%31K
-9.38%29K
2.40%128K
0.00%32K
3.23%32K
Operating profit
54.47%-14.73M
1.39%-27.27M
-38.80%-121.5M
-4.15%-32.61M
-21.19%-28.9M
-623.17%-32.34M
0.94%-27.65M
1.74%-87.54M
6.61%-31.31M
-2,021.44%-23.85M
Net non-operating interest income expense
-1.91M
-1.98M
-604K
0
0
0
Non-operating interest expense
--1.91M
--1.98M
--604K
----
----
--0
--0
--0
----
----
Other net income (expense)
-492.68%-3.38M
-247.11%-1.45M
73.99%3.59M
-9.71%874K
30.23%866K
223.68%861K
508.02%985K
221.03%2.06M
591.43%968K
499.10%665K
Special income (charges)
---4.07M
---2.4M
----
----
----
--0
--0
----
----
----
-Less：Restructuring and merger&acquisition
--2.58M
--2.4M
----
----
----
--0
--0
----
----
----
-Write off
--1.49M
----
----
----
----
--0
----
----
----
----
Other non- operating income (expenses)
-19.98%689K
-3.35%952K
73.99%3.59M
-9.71%874K
30.23%866K
223.68%861K
508.02%985K
221.03%2.06M
591.43%968K
499.10%665K
Income before tax
36.41%-20.02M
-15.12%-30.7M
-38.65%-118.51M
-6.59%-32.34M
-20.93%-28.03M
-648.43%-31.48M
3.91%-26.67M
3.35%-85.47M
9.12%-30.34M
-2,188.25%-23.18M
Income tax
Net income
36.41%-20.02M
-15.12%-30.7M
-38.65%-118.51M
-6.59%-32.34M
-20.93%-28.03M
-648.43%-31.48M
3.91%-26.67M
3.35%-85.47M
9.12%-30.34M
-2,188.25%-23.18M
Net income continuous Operations
36.41%-20.02M
-15.12%-30.7M
-38.65%-118.51M
-6.59%-32.34M
-20.93%-28.03M
-648.43%-31.48M
3.91%-26.67M
3.35%-85.47M
9.12%-30.34M
-2,188.25%-23.18M
Minority interest income
Net income attributable to the parent company
36.41%-20.02M
-15.12%-30.7M
-38.65%-118.51M
-6.59%-32.34M
-20.93%-28.03M
-648.43%-31.48M
3.91%-26.67M
3.35%-85.47M
9.12%-30.34M
-2,188.25%-23.18M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
36.41%-20.02M
-15.12%-30.7M
-38.65%-118.51M
-6.59%-32.34M
-20.93%-28.03M
-648.43%-31.48M
3.91%-26.67M
3.35%-85.47M
9.12%-30.34M
-2,188.25%-23.18M
Basic earnings per share
36.21%-0.37
-14.29%-0.56
-37.74%-2.19
-5.36%-0.59
-20.93%-0.52
-625.00%-0.58
5.77%-0.49
8.62%-1.59
11.11%-0.56
-2,050.00%-0.43
Diluted earnings per share
36.21%-0.37
-14.29%-0.56
-37.74%-2.19
-5.36%-0.59
-20.93%-0.52
-625.00%-0.58
5.77%-0.49
8.62%-1.59
11.11%-0.56
-2,050.00%-0.43
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022
Total revenue -85.71%991K-65.37%2.14M-49.92%20.97M-7.88%3M-55.00%4.87M-69.86%6.93M28.71%6.17M81.81%41.87M297.20%3.26M-46.66%10.81M
Operating revenue --0-75.47%1.51M-51.59%20.27M-29.32%2.31M-55.00%4.87M-69.86%6.93M28.71%6.17M81.81%41.87M297.20%3.26M-46.66%10.81M
Cost of revenue 0-76.06%620K-15.03%6.17M-71.46%608K-49.00%1.56M1.42M24.46%2.59M7.27M2.13M3.06M
Gross profit -82.03%991K-57.62%1.52M-57.24%14.79M111.85%2.4M-57.36%3.31M-76.02%5.52M31.97%3.58M50.26%34.6M37.76%1.13M-61.73%7.76M
Operating expense -58.48%15.72M-7.83%28.78M11.59%136.29M7.91%35M1.91%32.21M37.78%37.86M1.98%31.23M8.94%122.14M-5.55%32.44M47.71%31.6M
Selling and administrative expenses -15.24%6.37M-1.11%6.79M-8.23%27.65M2.39%6.55M-2.27%6.72M-0.32%7.51M-26.33%6.86M2.88%30.13M-44.29%6.4M17.59%6.88M
-General and administrative expense -15.24%6.37M-1.11%6.79M-8.23%27.65M2.39%6.55M-2.27%6.72M-0.32%7.51M-26.33%6.86M2.88%30.13M-44.29%6.4M17.59%6.88M
Research and development costs -69.29%9.31M-9.74%21.96M18.10%108.51M9.25%28.42M3.08%25.45M52.27%30.31M14.39%24.33M11.10%91.88M13.92%26.01M59.15%24.69M
Depreciation amortization depletion 25.81%39K3.45%30K1.56%130K21.88%39K-3.13%31K-3.13%31K-9.38%29K2.40%128K0.00%32K3.23%32K
-Depreciation and amortization 25.81%39K3.45%30K1.56%130K21.88%39K-3.13%31K-3.13%31K-9.38%29K2.40%128K0.00%32K3.23%32K
Operating profit 54.47%-14.73M1.39%-27.27M-38.80%-121.5M-4.15%-32.61M-21.19%-28.9M-623.17%-32.34M0.94%-27.65M1.74%-87.54M6.61%-31.31M-2,021.44%-23.85M
Net non-operating interest income expense -1.91M-1.98M-604K000
Non-operating interest expense --1.91M--1.98M--604K----------0--0--0--------
Other net income (expense) -492.68%-3.38M-247.11%-1.45M73.99%3.59M-9.71%874K30.23%866K223.68%861K508.02%985K221.03%2.06M591.43%968K499.10%665K
Special income (charges) ---4.07M---2.4M--------------0--0------------
-Less：Restructuring and merger&acquisition --2.58M--2.4M--------------0--0------------
-Write off --1.49M------------------0----------------
Other non- operating income (expenses) -19.98%689K-3.35%952K73.99%3.59M-9.71%874K30.23%866K223.68%861K508.02%985K221.03%2.06M591.43%968K499.10%665K
Income before tax 36.41%-20.02M-15.12%-30.7M-38.65%-118.51M-6.59%-32.34M-20.93%-28.03M-648.43%-31.48M3.91%-26.67M3.35%-85.47M9.12%-30.34M-2,188.25%-23.18M
Income tax
Net income 36.41%-20.02M-15.12%-30.7M-38.65%-118.51M-6.59%-32.34M-20.93%-28.03M-648.43%-31.48M3.91%-26.67M3.35%-85.47M9.12%-30.34M-2,188.25%-23.18M
Net income continuous Operations 36.41%-20.02M-15.12%-30.7M-38.65%-118.51M-6.59%-32.34M-20.93%-28.03M-648.43%-31.48M3.91%-26.67M3.35%-85.47M9.12%-30.34M-2,188.25%-23.18M
Minority interest income
Net income attributable to the parent company 36.41%-20.02M-15.12%-30.7M-38.65%-118.51M-6.59%-32.34M-20.93%-28.03M-648.43%-31.48M3.91%-26.67M3.35%-85.47M9.12%-30.34M-2,188.25%-23.18M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 36.41%-20.02M-15.12%-30.7M-38.65%-118.51M-6.59%-32.34M-20.93%-28.03M-648.43%-31.48M3.91%-26.67M3.35%-85.47M9.12%-30.34M-2,188.25%-23.18M
Basic earnings per share 36.21%-0.37-14.29%-0.56-37.74%-2.19-5.36%-0.59-20.93%-0.52-625.00%-0.585.77%-0.498.62%-1.5911.11%-0.56-2,050.00%-0.43
Diluted earnings per share 36.21%-0.37-14.29%-0.56-37.74%-2.19-5.36%-0.59-20.93%-0.52-625.00%-0.585.77%-0.498.62%-1.5911.11%-0.56-2,050.00%-0.43
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data